Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion type Assertion NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_head.
- NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion description "[The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_provenance.
- NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion evidence source_evidence_literature NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_provenance.
- NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion SIO_000772 17908970 NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_provenance.
- NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion wasDerivedFrom befree-20140225 NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_provenance.
- NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_assertion wasGeneratedBy ECO_0000203 NP927759.RAfAxhwNWLHE3HNlKGfJNjPyhpAkrhOiR1p7eGE0P10-4130_provenance.